Tag: VersaFilm

April 3, 2018

IntelGenx Reports Fourth Quarter and Full-Year 2017 Financial Results

IntelGenx Technologies (TSX-V:IGX) reported financial results for the fourth quarter and twelve-month periods ended December 31, 2017. All dollar amounts are...
December 11, 2017

IntelGenx Gets US Patent for Montelukast Product

IntelGenx announced it received a patent allowance from the United States Patent and Trademark Office.
November 10, 2017

IntelGenx Submits Canadian Clinical Trial Application

IntelGenx announced it submitted a clinical trial application to Health Canada for approval to start its Phase 2a proof of...
June 8, 2017

IntelGenx Gets US Patent for Topical Oral Film Technology

IntelGenx announced the US Patent and Trademark Office issued one for the company's topical oral films.
April 13, 2017

An Introduction to TSXV Life Science Stocks

Should you decide that the TSXV is right for you, the Investing News Network has compiled a list of some...
April 13, 2017

IntelGenx and RedHill Get Marketing Approval in Luxembourg

IntelGenx in collaboration with RedHill Biopharma announced the Ministry of Health of Luxembourg has granted national marketing authorization for RIZAPORT,...
April 4, 2017

IntelGenx Presents At Conference On Alzheimer's And Parkinson's Diseases

IntelGenx Technologies president and CEO Dr. Horst Zerbe discussed the Montelukast VersaFilm project at the International Conference on Alzheimer's &...